Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Phytoconstituents of Lantana camara L.: Rekindling Hope in the Cancer Treatment

Author(s): Ishita Kathuria, Mit Joshi, Bhoomika M. Patel and Mahaveer Dhobi*

Volume 18, Issue 5, 2022

Published on: 16 February, 2022

Article ID: e311221199740 Pages: 16

DOI: 10.2174/1573407218666211231123626

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

Background: Lantana camara L. belongs to the family Verbenaceae. It originated in Tropical America in Southern Georgia and the North of Texas, and was introduced in Calcutta, India, in the year 1809 as an ornamental hedge. The plant L. camara is also distributed in Southeast Asia, China, Australia, Brazil, West Indies, Kenya, Mexico, East Africa, and Tanzania. Many of its phytoconstituents possess medicinal properties which are used traditionally to treat fever, uterine hemorrhage, and excess menstrual discharge, chronic ulcers, rheumatism, gonorrhea, toothache, gastrointestinal pain, etc., and it has been used in Brazil for curing malaria, mange, headaches, colds, and fevers.

Objective: The review elaborates traditional practices related to Lantana camara L., its phytochemistry, and its role in various types of cancers..

Methods: The data on L. camara were collected through different online databases, like Web of Science, PubMed, Science Direct, Springer, and Google Scholar.

Results: Major phytoconstituents isolated from the plant shows anticancer activity, especially lantadene A-D, icterogenin, oleanolic acid, lantacamaric acid A, B, oleanonic acid, etc. In vitro and in vivo studies demonstrate the potential of the plant for various cancers. Certain extracts, isolated compounds, and their semi-synthetic derivatives have depicted a significant cytotoxic and anti-proliferative effect.

Conclusion: Clinical studies related to the therapeutic efficacy of Lantana camara L. are not yet established, therefore, making it crucial to direct future researches in this area.

Keywords: Lantana camara, phytoconstituents, skin cancer, breast cancer, lung cancer, colon cancer.

Graphical Abstract

[1]
WHO. Globocan 2020: Estimated number of deaths from 2020 to 2040. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?types=1&single_unit=500000 (Accessed June 6, 2021).
[2]
American cancer society 2021. Cancer facts and figures 2021 2021. 2021. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/14-Larynx-fact-sheet.pdf (Accessed June 27, 2021).
[3]
WHO. Globocan 2020:Cancer incidence and mortality statistics worldwide and by region 2020. 2020. Available from: https://gco.iarc.fr/today/home (Accessed June 6, 2021).
[4]
Ottoman, R.E.; Langdon, E.A.; Rochlin, D.B.; Smart, C.R. Side-effects of combined radiation and chemotherapy in the treatment of malignant tumors. Radiology, 1963, 81, 1014-1017.
[http://dx.doi.org/10.1148/81.6.1014] [PMID: 14101708]
[5]
Perrino, C.; Schiattarella, G.G.; Magliulo, F.; Ilardi, F.; Carotenuto, G.; Gargiulo, G.; Serino, F.; Ferrone, M.; Scudiero, F.; Carbone, A.; Trimarco, B.; Esposito, G. Cardiac side effects of chemotherapy: state of art and strategies for a correct management. Curr. Vasc. Pharmacol., 2014, 12(1), 106-116.
[http://dx.doi.org/10.2174/157016111201140327163302] [PMID: 22563720]
[6]
Aslam, M.S.; Naveed, S.; Ahmed, A.; Abbas, Z.; Gull, I.; Athar, M.A. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J. Cancer Ther., 2014, 5, 817-822.
[http://dx.doi.org/10.4236/jct.2014.58089]
[7]
Jungk, C.; Chatziaslanidou, D.; Ahmadi, R.; Capper, D.; Bermejo, J.L.; Exner, J.; von Deimling, A.; Herold-Mende, C.; Unterberg, A. Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients. BMC Cancer, 2016, 16, 81.
[http://dx.doi.org/10.1186/s12885-016-2131-6] [PMID: 26865253]
[8]
National Cancer Institute. Surgery for Cancer 2021. 2021.
[9]
Vrouenraets, M.B.; Visser, G.W.; Snow, G.B.; van Dongen, G.A. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res., 2003, 23(1B), 505-522.
[PMID: 12680139]
[10]
Falk, M.H.; Issels, R.D. Hyperthermia in oncology. Int. J. Hyperthermia, 2001, 17(1), 1-18.
[http://dx.doi.org/10.1080/02656730150201552] [PMID: 11212876]
[11]
Bensadoun, R-J.; Riesenbeck, D.; Lockhart, P.B.; Elting, L.S.; Spijkervet, F.K.L.; Brennan, M.T. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support. Care Cancer, 2010, 18(8), 1033-1038.
[http://dx.doi.org/10.1007/s00520-010-0847-4] [PMID: 20213237]
[12]
Brook, I. Late side effects of radiation treatment for head and neck cancer. Radiat. Oncol. J., 2020, 38(2), 84-92.
[http://dx.doi.org/10.3857/roj.2020.00213] [PMID: 33012151]
[13]
Johnston, J.R.; Jacox, H.W. Rectal hemorrhage following irradiation for carcinoma of cervix. Am. J. Obstet. Gynecol., 1948, 55(5), 891-893.
[http://dx.doi.org/10.1016/0002-9378(48)90020-9] [PMID: 18914256]
[14]
WebMd. Side-effects of radiation therapy for cancer treatment 2021. 2021. Available from: https://www.webmd.com/cancer/what-to-expect-from-radiation-therapy (Accessed June6, 2021).
[15]
Möller, P.; Perrier, M.; Ozsahin, M.; Monnier, P. A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynx. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2004, 97(2), 173-189.
[http://dx.doi.org/10.1016/S1079-2104(03)00473-6] [PMID: 14970776]
[16]
Chan, H.K.; Ismail, S. Side effects of chemotherapy among cancer patients in a Malaysian General Hospital: Experiences, perceptions and informational needs from clinical pharmacists. Asian Pac. J. Cancer Prev., 2014, 15(13), 5305-5309.
[http://dx.doi.org/10.7314/APJCP.2014.15.13.5305] [PMID: 25040993]
[17]
Goodman, M. Managing the side effects of chemotherapy. Semin. Oncol. Nurs., 1989, 5(2)(Suppl. 1), 29-52.
[http://dx.doi.org/10.1016/0749-2081(89)90080-6] [PMID: 2657931]
[18]
Love, R.R.; Leventhal, H.; Easterling, D.V.; Nerenz, D.R. Side effects and emotional distress during cancer chemotherapy. Cancer, 1989, 63(3), 604-612.
[http://dx.doi.org/10.1002/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2] [PMID: 2912536]
[19]
Sitzia, J.; Huggins, L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Pract., 1998, 6(1), 13-21.
[http://dx.doi.org/10.1046/j.1523-5394.1998.1998006013.x] [PMID: 9460322]
[20]
Kayl, A.E.; Meyers, C.A. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr. Opin. Obstet. Gynecol., 2006, 18(1), 24-28.
[http://dx.doi.org/10.1097/01.gco.0000192996.20040.24] [PMID: 16493256]
[21]
Sun, C.C.; Bodurka, D.C.; Weaver, C.B.; Rasu, R.; Wolf, J.K.; Bevers, M.W.; Smith, J.A.; Wharton, J.T.; Rubenstein, E.B. Rankings and symptom assessments of side effects from chemotherapy: Insights from experienced patients with ovarian cancer. Support. Care Cancer, 2005, 13(4), 219-227.
[http://dx.doi.org/10.1007/s00520-004-0710-6] [PMID: 15538640]
[22]
Partridge, A.H.; Burstein, H.J.; Winer, E.P. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J. Natl. Cancer Inst. Monogr., 2001, (30), 135-142.
[http://dx.doi.org/10.1093/oxfordjournals.jncimonographs.a003451] [PMID: 11773307]
[23]
Khan, U.; Ali, F.; Khurram, M.S.; Zaka, A.; Hadid, T. Immunotherapy-associated autoimmune hemolytic anemia. J. Immunother. Cancer, 2017, 5, 15.
[http://dx.doi.org/10.1186/s40425-017-0214-9] [PMID: 28239468]
[24]
Scotté, F.; Ratta, R.; Beuzeboc, P. Side effects of immunotherapy: A constant challenge for oncologists. Curr. Opin. Oncol., 2019, 31(4), 280-285.
[http://dx.doi.org/10.1097/CCO.0000000000000541] [PMID: 30925538]
[25]
Cukier, P.; Santini, F.C.; Scaranti, M.; Hoff, A.O. Endocrine side effects of cancer immunotherapy. Endocr. Relat. Cancer, 2017, 24(12), T331-T347.
[http://dx.doi.org/10.1530/ERC-17-0358] [PMID: 29025857]
[26]
Castinetti, F.; Albarel, F.; Archambeaud, F.; Bertherat, J.; Bouillet, B.; Buffier, P.; Briet, C.; Cariou, B.; Caron, P.; Chabre, O.; Chanson, P.; Cortet, C.; Do Cao, C.; Drui, D.; Haissaguerre, M.; Hescot, S.; Illouz, F.; Kuhn, E.; Lahlou, N.; Merlen, E.; Raverot, V.; Smati, S.; Verges, B.; Borson-Chazot, F. French endocrine society guidance on endocrine side effects of immunotherapy. Endocr. Relat. Cancer, 2019, 26(2), G1-G18.
[http://dx.doi.org/10.1530/ERC-18-0320] [PMID: 30400055]
[27]
Kroschinsky, F.; Stölzel, F.; von Bonin, S.; Beutel, G.; Kochanek, M.; Kiehl, M.; Schellongowski, P. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management. Crit. Care, 2017, 21(1), 89.
[http://dx.doi.org/10.1186/s13054-017-1678-1] [PMID: 28407743]
[28]
Kumar, R.J.; Barqawi, A.; Crawford, E.D. Adverse events associated with hormonal therapy for prostate cancer. Rev. Urol., 2005, 7(Suppl. 5), S37-S43.
[PMID: 16985883]
[29]
Ziółkowska, E.; Zarzycka, M.; Wiśniewski, T.; Żyromska, A. The side effects of hormonal therapy at the patients with prostate cancer. Contemp. Oncol. (Pozn.), 2012, 16(6), 491-497.
[http://dx.doi.org/10.5114/wo.2012.32478] [PMID: 23788934]
[30]
Schilder, C.M.T.; Schagen, S.B. Effects of hormonal therapy on cognitive functioning in breast cancer patients: A review of the literature. Minerva Ginecol., 2007, 59(4), 387-401.
[PMID: 17923830]
[31]
Morton, J.F. Lantana, Or Red Sage (Lantana Camara L., [Verbenaceae]), Notorious Weed And Popular Garden Flower; Some Cases of Poisoning in Florida. Econ. Bot., 1994, 48, 259-270.
[http://dx.doi.org/10.1007/BF02862327]
[32]
Kohli, R.K.; Batish, D.R.; Singh, H.P.; Dogra, K.S. Status, invasiveness and environmental threats of three tropical American invasive weeds (Parthenium hysterophorus L., Ageratum conyzoides L., Lantana camara L.) in India. Biol. Invasions, 2006, 8, 1501-1510.
[http://dx.doi.org/10.1007/s10530-005-5842-1]
[33]
Ghisalberti, E.L. Lantana camara L. (Verbenaceae). Fitoterapia, 2000, 71(5), 467-486.
[http://dx.doi.org/10.1016/S0367-326X(00)00202-1] [PMID: 11449493]
[34]
Ross, I.A. Medicinal Plants of the World: Chemical Constituents; Traditional and Modern Medicinal Uses, 2003.
[http://dx.doi.org/10.1007/978-1-59259-365-1]
[35]
Sharma, M.; Sharma, P.D.; Bansal, M.P.; Singh, J. Synthesis, cytotoxicity, and antitumor activity of lantadene-A congeners. Chem. Biodivers., 2007, 4(5), 932-939.
[http://dx.doi.org/10.1002/cbdv.200790082] [PMID: 17511006]
[36]
Gomes de Melo, J.; de Sousa Araújo, T.A.; Thijan Nobre de Almeida e Castro, V.; Lyra de Vasconcelos Cabral, D.; do Desterro Rodrigues, M.; Carneiro do Nascimento, S.; Cavalcanti de Amorim, E.L.; de Albuquerque, U.P. Antiproliferative activity, antioxidant capacity and tannin content in plants of semi-arid northeastern Brazil. Molecules, 2010, 15(12), 8534-8542.
[http://dx.doi.org/10.3390/molecules15128534] [PMID: 21107308]
[37]
Gupta, S.; Kalani, K.; Saxena, M.; Srivastava, S.K.; Agrawal, S.K.; Suri, N.; Saxena, A.K. Cytotoxic evaluation of semisynthetic ester and amide derivatives of oleanolic acid. Nat. Prod. Commun., 2010, 5(10), 1567-1570.
[http://dx.doi.org/10.1177/1934578X1000501010] [PMID: 21121249]
[38]
Srivastava, P.; Kasoju, N.; Bora, U.; Chaturvedi, R. Accumulation of betulinic, oleanolic, and ursolic acids in in vitro cell cultures of Lantana camara L. and their significant cytotoxic effects on HeLa cell lines. Biotechnol. Bioprocess Eng.; BBE, 2010, 15, 1038-1046.
[http://dx.doi.org/10.1007/s12257-010-0054-7]
[39]
Litaudon, M.; Jolly, C.; Le Callonec, C.; Cuong, D.D.; Retailleau, P.; Nosjean, O.; Nguyen, V.H.; Pfeiffer, B.; Boutin, J.A.; Guéritte, F. Cytotoxic pentacyclic triterpenoids from Combretum sundaicum and Lantana camara as inhibitors of Bcl-xL/BakBH3 domain peptide interaction. J. Nat. Prod., 2009, 72(7), 1314-1320.
[http://dx.doi.org/10.1021/np900192r] [PMID: 19572612]
[40]
Shamsee, Z.R.; Al, A.Z.; Ahmed, S.; Shanon, F.; A.l., ; A.l., J.R. Cytotoxic and cell cycle arrest induction of pentacyclic triterpenoides separated from Lantana camara leaves against MCF-7 cell line in vitro. Mol Biol Rep, 2018, 46, 381-390.
[http://dx.doi.org/10.1007/s11033-018-4482-3]
[41]
Sharma, O.P.; Sharma, S.; Dawra, R.K. Reversed-phase high-performance liquid chromatographic separation and quantification of lantadenes using isocratic systems. J. Chromatogr. A, 1997, 786, 181-184.
[http://dx.doi.org/10.1016/S0021-9673(97)00536-0]
[42]
Sharma, O.P.; Vaid, J.; Sharma, P.D. Comparison of lantadenes content and toxicity of different taxa of the lantana plant. J. Chem. Ecol., 1991, 17(11), 2283-2291.
[http://dx.doi.org/10.1007/BF00988008] [PMID: 24258606]
[43]
Sharma, M.; Sharma, P.D.; Bansal, P.; Singh, J. Synthesis and antitumor activity of novel pentacyclic triterpenoid Lantadene D. Lett. Drug. Discov., 2007, 4(3), 201-206.
[http://dx.doi.org/10.2174/157018007780077471]
[44]
Hiremath, K.Y.; Jagadeesh, N.; Belur, S.; Kulkarni, S.S.; Inamdar, S.R. A lectin with anti-microbial and anti proliferative activities from Lantana camara, a medicinal plant. Protein Expr. Purif., 2020, 170, 105574.
[http://dx.doi.org/10.1016/j.pep.2020.105574] [PMID: 31978534]
[45]
Ono, M.; Hashimoto, A.; Miyajima, M.; Sakata, A.; Furusawa, C.; Shimode, M. Two new triterpenoids from the leaves and stems of Lantana camara. Nat. Prod. Res., 2020, 81, 1-9.
[PMID: 32141312]
[46]
Ghosh, S.; Das Sarma, M.; Patra, A.; Hazra, B. Anti-inflammatory and anticancer compounds isolated from Ventilago madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn. J. Pharm. Pharmacol., 2010, 62(9), 1158-1166.
[http://dx.doi.org/10.1111/j.2042-7158.2010.01151.x] [PMID: 20796195]
[47]
Kazmi, I.; Narooka, A.R.; Afzal, M.; Singh, R.; Al-Abbasi, F.A.; Ahmad, A.; Anwar, F. Anticancer effect of ursolic acid stearoyl glucoside in chemically induced hepatocellular carcinoma. J. Physiol. Biochem., 2013, 69(4), 687-695.
[http://dx.doi.org/10.1007/s13105-013-0245-8] [PMID: 23512248]
[48]
WHO. Radiation: Ultraviolet (UV) radiation and skin cancer 2017. 2017. Available from: https://www.who.int/news- room/q-a-detail/radiation-ultraviolet-(uv)-radiation-and-skin- cancer (Accessed June 27, 2021).
[49]
WHO. Globocan 2020: Estimated number of new cases for Non-melanoma skin cancer from 2020 to 2040. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=17&single_unit=50000&years=2040 (Accessed June 27, 2021).
[50]
WHO. Globocan 2020 : Estimated number of new cases for melanoma of skin from 2020 to 2040. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=16&single_unit=50000&years=2040 (Accessed June 27, 2021).
[51]
Raghu, C.; Ashok, G.; Dhanaraj, S.A. in vitro cytotoxic activity of Lantana camara Linn. Ind. J. pharmacol., 2020, 549, 95-96.
[52]
Tailor, N.K.; Boon, H.L.; Sharma, M. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes. Eur. J. Med. Chem., 2013, 64, 285-291.
[http://dx.doi.org/10.1016/j.ejmech.2013.04.009] [PMID: 23644211]
[53]
Sharma, M.; Sharma, P.D.; Bansal, M.P. Chemopreventive effect of lantana camara leaf extract on 7, 12-Dimethylbenz [ a ] anthracene- induced squamous cell carcinoma of skin in swiss albino mice chemopreventive effect of lantana camara leaf extract on 7, 12-Dimethylbenz [ a ] anthracene-Induc. Pharm. Biol., 2008, 0209, 145-148.
[http://dx.doi.org/10.1080/13880200601113115]
[54]
Kaur, J.; Sharma, M.; Sharma, P.D.; Bansal, M.P. Chemopreventive activity of lantadenes on two-stage carcinogenesis model in Swiss albino mice: AP-1 (c-jun), NFkappaB (p65) and P53 expression by ELISA and immunohistochemical localization. Mol. Cell. Biochem., 2008, 314(1-2), 1-8.
[http://dx.doi.org/10.1007/s11010-008-9758-9] [PMID: 18425423]
[55]
Kaur, J.; Sharma, M.; Sharma, P.D.; Bansal, M.P. Antitumor activity of lantadenes in DMBA/TPA induced skin Tumors in mice: Expression of transcription factors. Am. J. Biomed. Sci., 2010, 2, 79-90.
[http://dx.doi.org/10.5099/aj100100079]
[56]
Sharma, M.; Rakhi, A.; Dalal, N. Design, synthesis and evaluation of lantadene A congener with hydroxyl functionality in ring A as an antitumour agent. Nat. Ind. Res., 2011, 25, 37-41.
[http://dx.doi.org/10.1080/14786411003792173]
[57]
Inada, A.; Nakanishi, T.; Tokuda, H.; Nishino, H.; Sharma, O.P. Anti-tumor promoting activities of lantadenes on mouse skin tumors and mouse hepatic tumors. Planta Med., 1997, 63(3), 272-274.
[http://dx.doi.org/10.1055/s-2006-957673] [PMID: 9225615]
[58]
WHO. Globocan 2020: Breast cancer 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf (Accessed June 27, 2021).
[59]
Han, E.B.; Chang, B.Y.; Jung, Y.S. Lantana camara induces apoptosis by Bcl-2 family and caspases activation. Pathol. Qucol. Res., 2015, 21, 325-331.
[http://dx.doi.org/10.1007/s12253-014-9824-4]
[60]
Kumar, S.S.; Tailor, N.; Lee, H.B.; Sharma, M. Reduced Lantadenes A and B: Semi-synthetic synthesis, selective cytotoxicity, apoptosis induction and inhibition of NO, TNF-α production in HL-60 cells. Med. Chem. Res., 2013, 22, 3379-3388.
[http://dx.doi.org/10.1007/s00044-012-0354-x]
[61]
Ramkumar, R.; Balasubramani, G.; Raja, R.K.; Raja, M.; Govindan, R.; Girija, E.K.; Perumal, P. Lantana camara Linn root extract-mediated gold nanoparticles and their in vitro antioxidant and cytotoxic potentials. Artif. Cells Nanomed. Biotechnol., 2017, 45(4), 748-757.
[http://dx.doi.org/10.1080/21691401.2016.1276923] [PMID: 28064507]
[62]
Jaafar, N.D.; Al-Saffar, A.Z.; Yousif, E.A. Genotoxic and cytotoxic activities of lantadene a-loaded gold nanoparticles (LA-AuNPS) in MCF-7 cell line: An in vitro assessment. Int. J. Toxicol., 2020, 39(5), 422-432.
[http://dx.doi.org/10.1177/1091581820938329] [PMID: 32662347]
[63]
WHO. Globocan 2020:Lung cancer 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf (Accessed June 27, 2021).
[64]
Sharma, M.; Sharma, S.B. Anticancer activity of Lantana Camara hexane extract against brain carcinoma. Int. J. Chem. Biol. Sci., 2020, 2, 1-3.
[65]
Suthar, S.K.; Boon, H.L.; Sharma, M. Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: Synthesis and evaluation of lantadene congeners. Eur. J. Med. Chem., 2014, 74, 135-144.
[http://dx.doi.org/10.1016/j.ejmech.2013.12.052] [PMID: 24457265]
[66]
Monika, ; Sharma, A.; Suthar, S.K.; Aggarwal, V.; Lee, H.B.; Sharma, M. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation. Bioorg. Med. Chem. Lett., 2014, 24(16), 3814-3818.
[http://dx.doi.org/10.1016/j.bmcl.2014.06.068] [PMID: 25027934]
[67]
Sharma, M.; Sharma, P.D.; Bansal, M.P. Lantadenes and their esters as potential antitumor agents. J. Nat. Prod., 2008, 71(7), 1222-1227.
[http://dx.doi.org/10.1021/np800167x] [PMID: 18553923]
[68]
WHO. Globocan 2020:Colon cancer 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/8-Colon-fact-sheet.pdf (Accessed June 27, 2021).
[69]
Kawatra, S.; Taranalli, A.D.; Gaidhani, S.; Khanduri, S.; Reddy, J.E. Protective effect of Lantana Camara l. against 1,2– dimethyl hydrazine induced colon cancer in rats. World J. Pharm. Pharm. Sci., 2015, 4, 845-860.
[70]
WHO. Globocan 2020: Leukaemia 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/36-Leukaemia-fact-sheet.pdf (Accessed June 27, 2021).
[71]
Pour, B.M.; Sasidharan, S.; Jegathambigai, R.N.; Surash, R. Anti-leukemia activity of methanolic extracts of Lantana camara. Pharmacognosy Res., 2009, 1, 274-279.
[72]
Sharma, M.; Sharma, P.D.; Bansal, M.P.; Singh, J. Lantadene A-induced apoptosis in human leukemia HL-60 cells. Indian J. Pharmacol., 2007, 39, 140-144.
[http://dx.doi.org/10.4103/0253-7613.33433]
[73]
Herbert, J.M.; Maffrand, J.P.; Taoubi, K.; Augereau, J.M.; Fouraste, I.; Gleye, J. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J. Nat. Prod., 1991, 54(6), 1595-1600.
[http://dx.doi.org/10.1021/np50078a016] [PMID: 1812212]
[74]
WHO. Globocan 2020:Liver cancer 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf (Accessed June 27, 2021).
[75]
Bisi-Johnson, M.A.; Obi, C.L.; Hattori, T.; Oshima, Y.; Li, S.; Kambizi, L.; Eloff, J.N.; Vasaikar, S.D. Evaluation of the antibacterial and anticancer activities of some South African medicinal plants. BMC Complement. Altern. Med., 2011, 11, 14.
[http://dx.doi.org/10.1186/1472-6882-11-14] [PMID: 21329526]
[76]
Bhaskar, D.; Mashrea, D.S.; Amresh, N.; Sathyamurthy, B. In vitro studies on the effect of Lantana camara Linn. in liver cancer HepG2 cell lines. Eur. J. Pharm. Med. Res., 2017, 4, 539-545.
[77]
Kazmi, I.; Rahman, M.; Afzal, M.; Gupta, G.; Saleem, S.; Afzal, O.; Shaharyar, M.A.; Nautiyal, U.; Ahmed, S.; Anwar, F. Anti-diabetic potential of ursolic acid stearoyl glucoside: A new triterpenic gycosidic ester from Lantana camara. Fitoterapia, 2012, 83(1), 142-146.
[http://dx.doi.org/10.1016/j.fitote.2011.10.004] [PMID: 22051701]
[78]
WHO. Globocan 2020:Cervix uteri 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-uteri- fact-sheet.pdf (Accessed June 27, 2021).
[79]
WHO. Globocan 2020:Incidence, mortality and prevalence by cancer site 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf (Accessed June 27, 2021).
[80]
Mistry, K.N. in vitro Antioxidant and cytotoxic effects of methanol extracts of vitex negundo, lantana camara, bauhinia variegata and bauhinia racemosa on human cancer cell lines. Indian J. Pharm. Sci., 2017, 79, 431-437.
[http://dx.doi.org/10.4172/pharmaceutical-sciences.1000246]
[81]
WHO. Globocan 2020: Larynx 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/14-Larynx-fact-sheet.pdf (Accessed June 27, 2021).
[82]
WHO. Globocan 2020:Estimated number of new cases for larynx cancer from 2020 to 2040. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=14&single_unit=5000&years=2040&types=0&sexes=1 (Accessed June 27, 2021).
[83]
WHO. Globocan 2020: Estimated number of new cases for Non-Hodgkin lymphoma IN 2020. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=34&single_unit=5000&years=2040&types=0&sexes=0 (Accessed June 27, 2021).
[84]
WHO. Globocan 2020: Estimated number of new cases for Hodgkin lymphoma from 2020 to 2040. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=33&single_unit=5000&years=2040&types=0&sexes=0 (Accessed June 27, 2021).
[85]
WHO. Globocan 2020 - lip, oral cavity cancer 2020. 2020. Available from: http://gco.iarc.fr/today/data/factsheets/cancers/1-Lip-oral-cavity-fact-sheet.pdf (Accessed June 27, 2021).
[86]
WHO. Globocan 2020: estimated number of new cases for lip, oral cavity cancer from 2020 to 2040. 2020. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/isotype?cancers=1&single_unit=50000&years=2040&types=0 (Accessed June 27, 2021).
[87]
WHO. Globocan 2020: Brain, central nervous system cancer 2020. 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/31-Brain-central-nervous-system-fact-sheet.pdf (Accessed June 27, 2021).
[88]
Sarwar, S.; Dietz, B.; Ping, Y.; Bibi, Y.; Nisa, S.; Chaudhary, M.F. Novel anti-uterus cancer potential of fruit extract of Lantana camara as exhibited through the inhibition of alkaline phosphatase in human endometrial adenocarcinomatic cell line. J. Med. Plants Res., 2013, 7, 1216-1221.
[89]
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell, 2011, 144(5), 646-674.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]

Rights & Permissions Print Cite
Article Metrics
38
1
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy